Chemical Pathology Webinars 2021 (Lipids: Investigation & Management of Hypertriglyceridaemia) [0]
Course sponsor: The Association of Clinical Pathologists
Dr Claire Meek and colleagues will present a series of monthly seminars throughout 2021. Lipids: Investigation & management of hypertriglyceridaemia.   Contact hours - 1.00
April 15, 2021; 01:00 PM, UTC +01:00

Write your comment | Read users' comments | Rate this link 

Classical Hodgkin Lymphoma - Pathology and Biology [0]
Course sponsor: ISLH - The International Society for Laboratory Hematology
Dr. Hsi will review the pathologic features of classic Hodgkin lymphoma, discuss differential diagnostic considerations, and review recent advances in our understanding of the biology of Hodgkin lymphoma with an emphasis on molecular genetic and micrcoenvironmental features. Learning Objectives - after participation of this activity, participants will be able to: 1. Describe the pathologic features of Hodgkin lymphoma 2. List entities in the differential diagnosis of Hodgkin lymphoma 3. Describe common genetic abnormalities in Hodgkin lymphoma   Contact hours - 1.00
April 15, 2021; 11:00 AM, UTC -04:00

Write your comment | Read users' comments | Rate this link 

COVID-19 and the Transition to a Digital Pathology Workflow [0]
Course sponsor: National Society for Histotechnology (NSH)
COVID-19 has drastically changed laboratory workflow, staffing, and practices. With these changes more and more facilities are transitioning to a digital solution. This webinar will discuss changes in workflow and highlight how a digital pathology solution is being used.   Contact hours - 1.00
April 28, 2021; 01:00 PM, UTC -04:00

Write your comment | Read users' comments | Rate this link 

ERBB2 (HER2) in Colorectal Cancer: Recent Findings, Laboratory Considerations, and Clinical Implications [0]
Course sponsor: Association for Molecular Pathology (AMP)
The human epidermal growth factor receptor 2 gene ERBB2 (HER2) is amplified in many cancer types. Overexpression of ERBB2 has been used successfully as a therapeutic target in breast and gastric cancers with a variety of anti-ERBB2 agents. In contrast, the role of ERBB2 in colorectal cancer is not as well established. Molecular characterization of colorectal cancer has identified ERBB2 amplification as a potential therapeutic target and activation of ERBB2 signaling causes resistance to anti-EGFR therapy in a subset of patients with metastatic colorectal cancer. The biology and clinicopathologic correlations of ERBB2 amplification in colorectal cancer, as well as testing strategies to optimize detection of this alteration in clinical practice, will be addressed in this presentation. Learning Objectives: Describe the biological principles that underlie the role of ERBB2 amplification in cancer, with a focus on its role in colorectal cancer Discuss the appropriate technical approaches and platforms for testing for ERBB2 amplification Outline the strengths and limitations of described testing approaches Discuss interpretation of biomarker status results within a clinical context   Contact hours - 1.00
April 15, 2021; 12:00 PM, UTC -04:00

Write your comment | Read users' comments | Rate this link 

HALO And HALO AI 3.3 Sneak Peek [0]
Course sponsor: Indica Labs
The upcoming release of HALO and HALO AI contains many exciting improvements that we wanted to share with our users! In this 30 minute webinar, we will announce the new developments within our products and give a live demonstration of the expanded, pathologist-oriented workflows, including: AI Phenotyper embedded within HALO analysis modules Train, Test, Validate workflow when optimizing an AI classifier Improved study search and direct link to images hosted on HALO Link A redesign of Advanced Export, including a flow cytometry file format Automatic application of ICC profile color correction and more!   Contact hours - 1.00
April 22, 2021; 08:00 AM, UTC -07:00

Write your comment | Read users' comments | Rate this link 

Mapping Your Path to Successful Digital Pathology Deployment [0]
Course sponsor: Leica Biosystems
Are you planning to implement digital pathology in your lab? Are you looking to understand the benefits of the investment or need help with handling objections and obstacles? To help you drive change and strengthen your knowledge in the topic, you can virtually meet the peers that have successfully implemented digital pathology for routine diagnosis in their lab. You will learn more about the barriers they encountered and how they overcame them, as well as find out what ROI they generated by embracing digital pathology.   Contact hours - 1.00
April 22, 2021; 01:00 PM, UTC +01:00

Write your comment | Read users' comments | Rate this link 

Pathology of Diabetic Nephrology [0]
Course sponsor: Renal Pathology Society
The RPS promotes excellence in diagnosis, fosters basic, clinical and translational research, encourages training and education in renal disease, sponsors US based and international conferences and symposia, and brings news and updates pertaining to renal pathology to its members around the world. The pathology of diabetic nephrophaty Speaker Neeraja Kambham, MD Professor, Department of Pathology Director, Renal Pathology & EM Lab Program Director, Renal Pathology Fellowship Stanford University Moderators: Benjamin Adam, University of Alberta Kammi Henriksen, University of Chicago   Contact hours - 1.00
April 16, 2021; 08:00 AM, UTC -07:00

Write your comment | Read users' comments | Rate this link 

Rous-Whipple Award Lecture (Pathology in Alzheimer Disease: A Protective Response?) [0]
Course sponsor: American Society for Investigative Pathology
George Perry, PhD ▪ University of Texas at San Antonio Pathology in Alzheimer Disease: A Protective Response? Introduction: Xiongwei Zhu, PhD Case Western Reserve University Dr. Perry will present the pathology of Alzheimer’s disease from the pathological perspective that places plaques and tangles as biological responses to metabolic and oxidative stress rather than the cause of disease. He will review his work demonstrating oxidative stress is the first abnormality of Alzheimer and that mitochondria, autophagy and metal redox chemistry are its source. In this mix, amyloid-ß reduced oxidative stress through Cu/Fe redox chemistry. This places the pathology as potentially protective, like inflammation, explaining why thirty years of focus and eventual success in removing pathology has not produced meaningful benefit for patients.   Contact hours - 1.00
April 27, 2021; 05:00 PM, UTC -04:00

Write your comment | Read users' comments | Rate this link 

Transforming Digital Pathology [0]
Course sponsor: Visiopharm
Digital Pathology has been improving the quality and speed of patient care forever and is rapidly becoming the new standard of care. However, this advancement demands a strong connection between the internet, laboratory information systems and electronic medical records that artificial intelligence could help solve. Integrating AI in digital pathology is a much needed and important step towards achieving a greater and profound impact on the patient experience. This webinar is scheduled to take place on 30th April 2021, 10:30 AM to 14:25 CET, and will serve as a platform to further discuss and understand the strength of digital pathology tied with AI. The webinar will provide an insight into the practical aspects of implementing digital pathology into clinics and applications in AI settings.   Contact hours - 4.00
April 30, 2021; 10:00 AM, UTC -05:00

Write your comment | Read users' comments | Rate this link